OMERACT endorsement of measures of outcome for studies of acute gout

Journal of Rheumatology

Volumn 41, Issue 3, 2014, Pages 569-573

  Singh, Jasvinder A ^a   Taylor, William J ^b   Dalbeth, Nicola ^c   Simon, Lee S ^d   Sundy, John ^e,f   Grainger, Rebecca ^b   Alten, Rieke ^g   March, Lyn ^h   Strand, Vibeke ⁱ   Wells, George ^j   Khanna, Dinesh ^k   McQueen, Fiona ^c   Schlesinger, Naomi ^l   Boonen, Annelies ^m   Boers, Maarten ⁿ   Saag, Kenneth G ^a   Schumacher, H Ralph ^o   Edwards, N Lawrence ^p  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d SDG LLC   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DUKE NUS MEDICAL SCHOOL   (Singapore)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ STANFORD UNIVERSITY   (United States)

^j UNIVERSITY OF OTTAWA   (Canada)

^k UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^l ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^m MAASTRICHT UNIVERSITY   (Netherlands)

ⁿ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^o UNIVERSITY OF PENNSYLVANIA   (United States)

^p UNIVERSITY OF FLORIDA   (United States)

more..

Author keywords

Gout; Outcome measures; Psychometrics

Indexed keywords

ARTHROPATHY; ARTICLE; DISEASE SEVERITY; EFFECT SIZE; GOUT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT SWELLING; JOINT TENDERNESS; LIKERT SCALE; MEASUREMENT ERROR; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUMERIC RATING SCALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT RESPONSE; VALIDATION PROCESS; VISUAL ANALOG SCALE;

GOUT; OUTCOME MEASURES; PSYCHOMETRICS;

CLINICAL TRIALS AS TOPIC; DISABILITY EVALUATION; GOUT; GOUT SUPPRESSANTS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; RHEUMATOLOGY; TREATMENT OUTCOME;

EID: 84895461120     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.131246     Document Type: Article

References (16)

1. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011;63:3136-41.
2. Schumacher HR, Taylor W, Edwards L, Grainger R, Schlesinger N, Dalbeth N, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol 2009;36:2342-5.
3. Taylor WJ, Singh JA, Saag KG, Dalbeth N, MacDonald PA, Edwards NL, et al. Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials. J Rheumatol 2011;38:1467-70.
4. Dalbeth N, McQueen FM, Singh JA, MacDonald PA, Edwards NL, Schumacher HR, Jr, et al. Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol 2011;38:1458-61.
5. Singh JA, Taylor WJ, Simon LS, Khanna PP, Stamp LK, McQueen FM, et al. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol 2011;38:1452-7.
6. Singh JA, Yang S, Strand V, Simon L, Forsythe A, Hamburger S, et al. Validation of pain and patient global scales in chronic gout: data from two randomised controlled trials. Ann Rheum Dis 2011;70:1277-81.
7. Stamp LK, Khanna PP, Dalbeth N, Boers M, Maksymowych WP, Schumacher HR Jr, et al. Serum urate in chronic gout - will it be the first validated soluble biomarker in rheumatology? J Rheumatol 2011;38:1462-6.
8. Grainger R, Taylor WJ, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, et al. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol 2009;36:2346-55.
9. Schumacher HR Jr, Taylor W, Edwards NL, Grainger R, Schlesinger N, Dalbeth N, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol 2009;36:2342-5.
10. Dalbeth N, Zhong CS, Grainger R, Khanna D, Khanna PP, Singh JA, et al. Outcome measures in acute gout: a systematic literature review. J Rheumatol 2014;41:558-68.
11. Taylor WJ, Redden D, Dalbeth N, Schumacher HR, Edwards L, Simon LS, et al. Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout. J Rheumatol 2014;41:574-80.
12. Schumacher HR Jr, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, et al. Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis. BMJ 2002;324:1488-92. (Pubitemid 34666615)
13. Bellamy N, Downie WW, Buchanan WW. Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol 1987;24:33-6. (Pubitemid 17087672)
14. Fries JF, Krishnan E, Rose M, Lingala B, Bruce B. Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory. Arthritis Res Ther 2011;13:R147.
15. Binkley J, Stratford P, Lott S, Riddle D, The North American Orthopaedic Rehabilitation Research Network. The Lower Extremity Functional Scale: Scale development, measurement properties, and clinical application. Phys Ther 1999;79:4371-83.
16. Rubin BR, Burton R, Navarra S, Antigua J, Londono J, Pryhuber KG, et al. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout. Arthritis Rheum 2004;50:598-606. (Pubitemid 38202232)